MoneyWorks4Me

Cadila Healthcare clarifies on news item

13 Nov 2017 Evaluate

The Exchange had sought clarification from Cadila Healthcare with respect to news appearing in www.livemint.com on November 10, 2017 titled ‘Zydus Cadila, Intas under scanner for launching hypertension drug without permit’. The company response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..